Related references
Note: Only part of the references are listed.Development and Validation of a Real-Time PCR Assay for Rapid Detection of Candida auris from Surveillance Samples
L. Leach et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
The Candida auris Alert: Facts and Perspectives
Frederic Lamoth et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model
Hamed Fakhim et al.
MYCOSES (2018)
The first isolate of Candida auris in China: clinical and biological aspects
Xiaojuan Wang et al.
EMERGING MICROBES & INFECTIONS (2018)
Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen
John Osei Sekyere
MICROBIOLOGYOPEN (2018)
Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species
Jose F. Munoz et al.
NATURE COMMUNICATIONS (2018)
Candida auris: What Have We Learned About Its Mechanisms of Pathogenicity?
Luana Rossato et al.
FRONTIERS IN MICROBIOLOGY (2018)
Fluconazole-Resistant Candida auris Is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses
Ruvini U. Pathirana et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Candida auris: a Review of the Literature
Anna Jeffery-Smith et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
Shawn R. Lockhart et al.
CLINICAL INFECTIOUS DISEASES (2017)
Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Health Care Surface
Rory M. Welsh et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi
Matthew W. McCarthy et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection
Alexander J. Lepak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Multidrug-Resistant Candida haemulonii and C-auris, Tel Aviv, Israel
Ronen Ben-Ami et al.
EMERGING INFECTIOUS DISEASES (2017)
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris
Leighann Sherry et al.
EMERGING INFECTIOUS DISEASES (2017)
Genome engineering in the yeast pathogen Candida glabrata using the CRISPR-Cas9 system
Ludovic Enkler et al.
SCIENTIFIC REPORTS (2016)
Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species
Andrew M. Borman et al.
MSPHERE (2016)
The growing promise of Toll-deficient Drosophila melanogaster as a model for studying Aspergillus pathogenesis and treatment
Michail S. Lionakis et al.
VIRULENCE (2010)
Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species
G Chamilos et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence
KV Clemons et al.
MEDICAL MYCOLOGY (2005)
Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence
MS Lionakis et al.
JOURNAL OF INFECTIOUS DISEASES (2005)